A team of urologists in Brussels estimate that a third of the men currently diagnosed with prostate cancer in their service could benefit from active surveillance, avoiding loss of quality of life. The Belgian doctors, led by Paul J Van Cangh, MD, are concerned that “widespread opportunistic PSA screening of prostate cancer has resulted in a large proportion of patients aggressively treated for low burden disease.” Reporting on the topic at this year’s annual meeting of the American Urological Association (AUA) in Anaheim California, May 19-24, they say: “Increased concern about overtreatment has led to the development of active surveillance protocols. Here we have reviewed pathological characteristics, disease free survival, and quality of life of patients treated by radical prostatectomy (RP) who might have been elected for active surveillance.”

Full story: Measuring Damage from “Over-Treatment” Of Indolent Prostate Cancer — Quality of Life Could Be Spared by Applying Selection Nomograms.